Quarterly report pursuant to Section 13 or 15(d)

RESTRUCTURING CHARGES (Tables)

v3.24.3
RESTRUCTURING CHARGES (Tables)
9 Months Ended
Sep. 30, 2024
RESTRUCTURING CHARGES  
Schedule of employee severance, benefits and related costs

During the nine months ended September 30, 2024 and 2023, the Company recorded the following activity related to the 2022 and 2024 Initiatives in accrued expenses and other current liabilities on the balance sheet (in thousands):

Nine Months Ended September 30, 

2024

2023

Accrued expenses, beginning of period

$

6,313

$

1,095

Restructuring charges

87,443

6,610

Cash payments

(4,230)

(2,317)

Inventory write-off

(1,739)

(2,484)

Depreciation and amortization of assets to be disposed

(80,329)

Accrued expenses, end of period

$

7,458

$

2,904

Schedule of restructuring and related costs

During the three and nine months ended September 30, 2024 and 2023, the Company recognized the following restructuring charges which were expensed as follows (in thousands):

Three Months Ended September 30, 

Nine Months Ended September 30, 

2024

2023

2024

2023

Cost of sales

$

1,785

$

16

$

46,398

$

3,221

Research and development

23

187

7,026

3,085

Sales and marketing

184

(62)

22,692

68

General and administrative

 

226

 

1

 

11,327

 

236

Total restructuring charges

$

2,218

$

142

$

87,443

$

6,610